Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction

被引：0
|
作者：
Malek, L. A. [1 ]
Klopotowski, M. [1 ]
Kostrzewa, G. [2 ]
Spiewak, M. [1 ]
Przyluski, J. [1 ]
Witkowski, A. [1 ]
机构：
[1] Natl Inst Cardiol, Warsaw, Poland
[2] Med Univ Warsaw, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [41] Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine
    Kim, Minhee
    Kong, Eunhee
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2012, 16 (05): : 339 - 342
  • [42] Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation
    Elmaagacli, A. H.
    Koldehoff, M.
    Steckel, N. K.
    Trenschel, R.
    Ottinger, H.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2007, 40 (07) : 659 - 664
  • [43] Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
    Zonios, Dimitrios
    Yamazaki, Hiroshi
    Murayama, Norie
    Natarajan, Ven
    Palmore, Tara
    Childs, Richard
    Skinner, Jeff
    Bennett, John E.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (12): : 1941 - 1948
  • [44] Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
    Wiese, Michael D.
    Schnabl, Matthew
    O'Doherty, Catherine
    Spargo, Llewellyn D.
    Sorich, Michael J.
    Cleland, Leslie G.
    Proudman, Susanna M.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
  • [45] Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation
    A H Elmaagacli
    M Koldehoff
    N K Steckel
    R Trenschel
    H Ottinger
    D W Beelen
    Bone Marrow Transplantation, 2007, 40 : 659 - 664
  • [46] Cytochrome P450 2C19 Inhibitory Activity of Common Berry Constituents
    Sand, Philipp G.
    Dreiseitel, Andrea
    Stang, Martin
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Hajak, Goeran
    PHYTOTHERAPY RESEARCH, 2010, 24 (02) : 304 - 307
  • [47] Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants
    Takeji, Shiori
    Okada, Mai
    Hayashi, Shu
    Kanamaru, Kengo
    Uno, Yuichi
    Imaishi, Hiromasa
    Uno, Tomohide
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (06) : 420 - 430
  • [48] Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
    Jiang, Rongrong
    Yamaori, Satoshi
    Okamoto, Yasuka
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (04) : 332 - 338
  • [49] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Bo Jin
    Huan-Chun Ni
    Wei Shen
    Jian Li
    Hai-Ming Shi
    Yong Li
    Molecular Biology Reports, 2011, 38 : 1697 - 1702
  • [50] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Jin, Bo
    Ni, Huan-Chun
    Shen, Wei
    Li, Jian
    Shi, Hai-Ming
    Li, Yong
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (03) : 1697 - 1702
12345